Biotechnology

Monday May 10, 2021 - 12:56 pm

Brain Scientific Inc. (BRSF) Receives First Purchase Order from Department of Veterans Affairs

First order marks a significant milestone as Veterans Affairs runs the largest integrated healthcare system in the countryBRSF hopes the relationship will bring cutting-edge brain diagnostics to a nationwide network of veterans’ health care Brain Scientific (OTCQB: BRSF), a commercial-stage, neurology-focused medical device and software company, has announced the start of working with the U.S. Department of Veterans Affairs – VA Medical Centers, which placed the first purchase order of NeuroCap(TM) for one of its hospitals (https://ibn.fm/p3rw0). This…

Monday May 10, 2021 - 12:19 pm

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Looks to New Senior Management with Expertise in Development, Clinical Capabilities

Company committed to building presence in U.S. and Europe to advance mission of improving mental health careNew appointments will strengthen Cybin’s development and clinical operations globally, solidify position within the industryNew leaders bring broad experience, deep insight to their new roles Cybin (NEO: CYBN) (OTCQB: CLXPF), a leading biotech company focused on progressing psychedelic therapeutics, recently made key senior-management changes designed to provide the company…

Friday May 07, 2021 - 2:20 pm

Brain Scientific Inc. (BRSF) Featured in Science and Technology Publication as Company Shaping the Future of Neurology Research

Brain Scientific was featured in Neoscope, a publication of Futurism, a media company concentrating on the scientific and technological advances for the futureArticle details e-tattoo, BRSF’s solution that can capture big data in real-time about brain activity with possible applications in epileptic seizure predictionsE-tattoo could prove invaluable to medical researchers studying neurological conditions or even developers building brain-computer interfaces for mind-controlled electronics, video games Brain…

Friday May 07, 2021 - 1:47 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Investigates Alleviating Neurological Disorders with Psychedelics

Tryp Therapeutics is a pharmaceutical developer working to produce novel bioscience solutions, including a synthetic psychedelic drug candidate for treating some chronic pain and eating disordersTryp CEO Greg McKee appeared on the Entrepreneur Magazine podcast “Action and Ambition” earlier this month to discuss lessons learned on his road to success and to highlight the company’s purpose in developing treatments for helping people be more wholePsychedelic…

Thursday May 06, 2021 - 10:45 am

Brain Scientific Inc. (BRSF) Eyes Plans for 2021 and Beyond

Commercial application of NeuroEEG and NeuroCap growing across ICUs, acute inpatient care and other emergency care in U.S.BRSF plans to launch devices in CanadaCompany expands footprint, plans patent applications in Latin America, Europe Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has unveiled the outlook for 2021. Brain Scientific continues to make strides within neurology by revolutionizing the brain diagnostic market with…

Wednesday May 05, 2021 - 12:07 pm

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Signs Drug-Development Agreement, One Step Closer to Effective Psychiatric Disorder Treatment

Agreement calls for Cybin, Catalent to work together to develop novel therapy for treatment-resistant psychiatric disordersCybin looking to identify fast-acting, shorter-duration formulations of CYB003Delivering CYB003 through Catalent ODT could provide significant benefits Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has inked a drug-development agreement with Catalent Inc. (NYSE: CTLT), a leading global provider of advanced delivery technologies, development, and…

Tuesday May 04, 2021 - 2:27 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Inks Distribution Agreement for Rapid COVID-19 Test Kits; Expands Commercial Leadership Team in Anticipation of Strong, Sustainable Sales

XPhyto Therapeutics Corp. recently announced it has entered into a distribution, storage and logistics agreement with a German distributor with an established network throughout GermanyGermany holds promise due to regulations requiring mandatory weekly testing for its citizens; this has the possibility of ramping up salesAnticipating the increase in sales and distribution, XPhyto expanded its commercial leadership team by bringing on board Mr. Wolfgang Probst and…

Tuesday May 04, 2021 - 11:48 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leading Charge in Developing Psychedelic Medicines for Treating Rare Eating Disorders

Pharmaceutical developer Tryp Therapeutics is targeting orphan disorders with novel medicinal solutionsThe company’s initial candidates seeking regulatory approval are a psilocybin compound for treating fibromyalgia, eating disorders and chronic pain conditions, as well as a tumor-inhibiting drug for treating soft tissue sarcomasTryp has partnered with the University of Florida to conduct a Phase 2a clinical trial for eating disorders using Tryp's psilocybin product Following a…

Tuesday May 04, 2021 - 9:00 am

RYAH Group About to Start Trading on Canadian Securities Exchange

RYAH Group to start trading on Canadian Securities Exchange following a transaction involving a triangular mergerRYAH Group is digital health care analytics and technology company developing innovative solutions for the plant-based medical industryRYAH is poised for growth as the world transitions to remote health at an accelerated pace due to the pandemic RYAH Group (formerly known as Prime Blockchain Inc.) will start trading on the…

Monday May 03, 2021 - 2:53 pm

DGE’s 4th Virtual Clinical Trials Conference

Monday, May 17, 2021 On Monday, May 17th, 2021, pharma companies, medical vendors, and clinicians are invited to attend the 4th Virtual Clinical Trials conference – the industry’s leading, longest-lasting conference on virtual clinical trials. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. The global event company caters to the dynamic informational and networking needs of the Pharmaceutical,…

Friday Apr 30, 2021 - 1:53 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Is ‘One to Watch’

Tryp Therapeutics is a pharmaceutical company with a focus on developing clinical-stage compounds for diseases with high unmet medical needs through accelerated regulatory pathwaysThe company currently has two drug candidates in development: TRP-8802 (targeting fibromyalgia, eating disorders and chronic pain conditions); and TRP-1001 (targeting soft tissue sarcomas)Through its PFN(TM) program, the company is focused on developing psilocybin-based drug therapies for certain neuropsychiatric disorders that offer…

Friday Apr 30, 2021 - 1:41 pm

United Medical Equipment Business Solutions Network Inc. Provides Solutions for Safer Workplaces

Routine virus testing is effective overall employer strategy for providing employee safety and business continuityMore research needs to be done on how long vaccines are effective, if booster shots will be neededOnly 26% of the U.S. is fully vaccinated; vaccinated individuals can still spread the virus United Medical Equipment Business Solutions Network provides solutions that fit the ever-changing needs of the nation’s workforce during the…

Thursday Apr 29, 2021 - 12:12 pm

Ryah Group Inc. Uses Big Data, AI to Reshape Plant-Based Medicine

RYAH recognizes the value data combined with analytics can bring to almost every industry.Company focused on becoming a technological leader in the plant-based treatment market.RYAH’s easy-to-operate line of products help foster a seamless dose-control experience that generates insightful data. A recent Forbes article called it the “oil” of the fourth industrial revolution (https://ibn.fm/x7inY) while a Gartner article noted it was a core function for businesses…

Thursday Apr 29, 2021 - 9:35 am

Burgeoning Plant-Based Health Products Market Holds Promise for Healthy Extracts Inc. (HYEX)

Healthy Extracts Inc. engages in proprietary R&D, sales and distribution of health products through its BergaMet North America and Ultimate Brain Nutrients (“UBN”) subsidiariesThe global brain health supplements, UBN’s domain, is projected to grow at a CAGR of 8% from 2021 to 2028The global heart health supplements market, BergaMet’s segment, is expected to witness a CAGR of 4.5% from 2020 to 2030Overall, the global botanical…

Wednesday Apr 28, 2021 - 9:58 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology Development is at the Forefront of Bladder Cancer Visualization Innovation

The i/Blue Imaging System’s(TM) development is the first to harness the power of white light and blue light visualization techniques with the added capability of displaying multiple images simultaneously which will help surgeons perform more accurate tumor resectionsImagin Medical’s innovative system is currently in the manufacturing phase with Lighthouse Imaging with product completion slated for 2022With its patented technology, the company is positioned to stake…

Tuesday Apr 27, 2021 - 10:35 am

Brain Scientific Inc. (BRSF) Receives FDA Clearance for Next-Gen NeuroCap

BRSF announced it has FDA clearance for next-gen NeuroCapThe newest version of the NeuroCap has added velcro strips, expanded size range to include pediatricsNew device can stay on the patient’s head for up to four hours Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare company, announced it has received clearance from the FDA for its next-generation NeuroCap(TM) (https://ibn.fm/RYmMH). This device is an advanced electroencephalogram (“EEG”) electrode…

Monday Apr 26, 2021 - 2:41 pm

DGE’s Women’s Executive Leadership Virtual Workshop 201 to Empower Leaders to Build Teams that Deliver Superior Results

May 10, 2021 Virtual Event Event Highlights The Women’s Executive Leadership Virtual Workshop 201 is an event designed for mid-level and senior leaders.The event scheduled for May 10 is meant to empower leaders to consider the input of the teams they oversee and build teams that can deliver exemplary results.The speaker, Colleen Hauk, is a seasoned trainer and leader with experience spanning 15 years. Described…

Friday Apr 23, 2021 - 11:32 am

Dynamic Global Events’ KOL & Thought Leader Engagement Summit April 28th -29th, 2021

Industry professionals are invited to attend the KOL & Thought Leader Engagement Summit, hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. The Global Event Company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries. The event timings on the first day are 8:30 am – 5:00 pm. The next day’s timings are…

Friday Apr 23, 2021 - 10:37 am

Brain Scientific Inc. (BRSF) Joins Forces with JelikaLite to Reduce Symptoms of Autism

BRSF and JelikaLite have joined forces in a clinical trial for reducing autism symptoms in childrenJelikaLite uses PRM therapy to reduce autism symptomsBRSF sees this as an important step forward in wider adoption of affordable, accessible EEG systems The neurology-focused medical device and software company Brain Scientific (OTCQB: BRSF) announced on March 16, 2021, it is collaborating with JelikaLite in a clinical trial. The clinical…

Wednesday Apr 21, 2021 - 10:23 am

United Medical Equipment Business Solutions Network Inc. Continues Commitment to Public Health

Company remains committed to helping maintain safety and health during global pandemicRapid testing identifies virus in the person, provides another layer of protection to the communityUME kits help identify the virus quickly allowing companies and individuals to act quickly to isolate infected individuals United Medical Equipment Business Solutions Network distributes rapid antigen tests and comprehensive telehealth solutions that allow providers to work more proficiently, health-care…

Tuesday Apr 20, 2021 - 9:27 am

Dynamic Global Events’ BioPharma BD&L Summit Accelerates Alliances, Licensing and Partnerships

The two-day virtual event to be held from April 22-23 is focused on driving collaborative partnerships to enhance the drug development ecosystem through the art of deal-makingThe summit is designed to provide insight into M&A, an attractive option for MedTech and pharmaceutical companies experiencing complex R&D, patent expirations and other impediments to growth20+ knowledgeable, esteemed speakers will grace the stage Companies view mergers and acquisitions…

Monday Apr 19, 2021 - 11:00 am

Healthy Extracts Inc. (HYEX) Reinforces its Foothold in the Broader Wellness Industry

Plant-based supplements gaining popularity for treating chronic cardiovascular and neuro ailmentsHealthy Extracts, Inc. intensifies its foothold through its subsidiaries BergaMet North America and Ultimate Brain NutrientsThe company recently announced positive results of clinical studies for two leading products, BergaMet North America’s HERHEART(TM) and UBN’s Fuel4Thought(TM) Brain Booster Plant-based diets (“PBD”) decrease the serum levels of inflammation by reducing levels of ROS (https://ibn.fm/tA2MU). Also, chronic neuropathic…

Friday Apr 16, 2021 - 12:16 pm

Largely Untapped Market for Hallucinogenic Draws Attention of Researchers at XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

XPhyto Therapeutics Corp., a life sciences technology accelerator, is looking for ways to turn promising psychedelics into therapeutic pharmaceutical drugs, and recently added mescaline to its study profileMescaline is illegal under U.S. federal law, but some state-centric efforts to legalize or decriminalize the hallucinogenic have launched in a manner similar to the populace effort that produced a wave of cannabis product legalizationMescaline has historically defied…

Monday Apr 12, 2021 - 1:02 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Files First Order for Rapid COVID Test Kits Amid European Regulatory Approval

Bioscience technology accelerator XPhyto Therapeutics Corp. recently announced it had placed its first order for its Covid-ID Lab rapid, portable virus test from its German development partnerXPhyto received approval for the test kit last month from European regulators with oversight of in vitro diagnostic device (CE-IVD) use certification and the internationally agreed-on ISO 13485 medical product quality standardsThe Covid-ID Lab is designed to help beleaguered…

Monday Apr 12, 2021 - 12:36 pm

Brain Scientific Inc. (BRSF) Changing the Landscape by Tackling Neurology Deserts

Distribution of neurologists across the U.S. is uneven with 20 states experiencing neurology desertsBrain Scientific has developed tools that help providers in neurology deserts provide access to neurological careWith explosion of telemedicine services and increased integration of advanced practice providers, neurologists' shortage may improve Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company, is directly tackling the shortage of neurologists in the United States with cutting-edge…

Friday Apr 09, 2021 - 2:27 pm

RYAH Group Inc. Offers IoT Suite of Products Disrupting Future of Medicine

Every product features three parts: dosing device, formulation accessory and mobile appHIPPA-compliant cloud collects data along each step that is essential in tailoring personalized treatment planRYAH offers multi-product ecosystem that provides remote-health solutions in patient treatment RYAH Group a digital health-care analytics and technology company, has developed an ecosystem of IoT products in its mission to advance the world's transition to remote-health solutions and data…

Thursday Apr 08, 2021 - 2:34 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Commercialization Team Set to Launch Rapid POC COVID Test Solution

Bioscience technology accelerator XPhyto Therapeutics Corp. is working with development partner 3a-diagnostics GmbH to roll out its pandemic-related virus diagnostic tool for the European market planned in AprilThe test solution, dubbed “Covid-ID Lab,” received European regulatory approval last monthXPhyto’s product is designed to be portable and rapid in its response time to help decrease testing operation costs and increase convenience of useNews reports about the…

Thursday Apr 08, 2021 - 1:11 pm

Brain Scientific Inc. (BRSF) Meeting the Needs of Neuro Research

BRSF is creating mobile, easy-to-use electroencephalogram (“EEG”) devices that enhance research integrityThere is an increasing desire to understand the brain’s capabilities and harness them for healingBrain Scientific provides a cost-efficient, pre-gelled, disposable and wireless solution that provides the same signal quality as the traditional wired EEG A growing consumer market for brain-computer interface (“BCI”) technology has some researchers worried about the quality of the data…

Wednesday Apr 07, 2021 - 2:44 pm

Patients with Incurable Brain Cancers Find New Hope in University Study, Upcoming CNS Pharmaceuticals (NASDAQ: CNSP) Clinical Trial

Glioblastoma Multiforme (often known simply as GBM) is a fatal, incurable class of brain cancers that usually leaves patients only about 15 months to live once they are diagnosedA recent study by the Washington University School of Medicine found that the length of survivability appeared to improve when the standard chemotherapy regimen was given in the morning instead of the eveningBrain cancer drug developer CNS…

Wednesday Apr 07, 2021 - 12:05 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Innovative Imaging Technology Overcoming Challenges Involving Bladder Cancer Visualization

90% of the cystoscopies performed on bladder cancer patients use white light, which cannot always detect cancer margins or tumors that lie flat against the bladder wall. The American Urology Association recommends blue light for cystoscopic procedures involving bladder cancer.Imagin Medical’s i/Blue Imaging System(TM) provides the simultaneous, side-by-side display of white light and blue light images, making it easier to visualize cancer margins and flat…

Tuesday Apr 06, 2021 - 1:04 pm

Healthy Extracts Inc.’s (HYEX) “Live Life Young Again” Strategy Reflects The Company’s Continued Optimism For 2021

Healthy Extracts Inc. recently declared its 2020 Q4 results, with revenue growth at 71% over the previous yearThe company’s 2021 strategy “Live Life Young Again” aligns with its plant-based product range and its overall confidence for 2021Results of the clinical studies of the Fuel4Thought Brain Booster product were published in the renowned World Journal of Advanced Research and Reviews Healthy Extracts (OTCQB: HYEX), is engaged in…

Thursday Apr 01, 2021 - 10:49 am

United Medical Equipment Business Solutions Network Inc. Positioned to Assist as Widespread Rapid Testing Gains Momentum

New York City ramps up rapid testing efforts, opens 11 rapid-testing sites; others to followMayor notes that low-cost, rapid-testing made available to public is key to accelerating economy's re-openingUME offers rapid -testing kits, provides products and services essential for curbing pandemic and jumpstarting economic recovery United Medical Equipment Business Solutions Network (“UME”), a trusted supplier of COVID-19 antigen and antibody testing kits, is offering a…

Monday Mar 29, 2021 - 11:26 am

Predictive Oncology’s (NASDAQ: POAI) Helomics Exec Talks AI, Big Data and Biology During Podcast Appearance

Convergence of AI, big data and biology allows Helomics to test drugs on living tumor tissue rather than artificial systemsHelomics model evaluates multiple measurements in powerful multi-omics approach to cancer researchKnowledge encapsulated by Helomics AI is “gold dust,” says chief innovation officer Data, AI and biology come together at Helomics in a way that promises exciting things for the future, according to Mark Collins, PhD and…

Friday Mar 19, 2021 - 3:46 pm

United Medical Equipment Business Solutions Network Positioned to Assist as Widespread Rapid Testing Gains Momentum

Friday Mar 19, 2021 - 2:14 pm

Predictive Oncology’s (NASDAQ: POAI) Skyline Medical Working on Gen 3 Fluid-to-Drain Liquid Waste Management System for Hospitals

Fluid management systems, accessories market forecast at 13.6% CAGR to $16.1 billion by 2025Skyline Medical’s STREAMWAY(R) System disrupts today’s standard of manually moving waste fluid for disposalSTREAMWAY Systems eliminates waste transport, disposal costs, equipment relocation and risk of exposure to potentially contaminated fluids. For every healthcare facility, particularly hospitals and surgical centers, disposal of waste fluids presents a unique set of challenges related not only…

Friday Mar 19, 2021 - 12:41 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Remains on Schedule to bring in Bladder Cancer Imaging System to Market

Bladder cancer is the fourth most common cancer in men andexpected to cause more than 17,000 deaths in the United States this yearImagin Medical is advancing its patented bladder cancer visualization technology toward commercialization and FDA approval, expecting the technology to revolutionize blue light cystoscopy procedures and improve patient outcomes in the processImagin is funding its efforts with $2.165 million raised towards its convertible note…

Wednesday Mar 17, 2021 - 2:02 pm

Imagin Medical (CSE: IME) (OTCQB: IMEXF), With Their Advanced i/Blue(TM) Imaging System, Closes Second Tranche of Convertible Note Offering

Imagin Medical is a surgical company focused on developing its i/Blue(TM) Imaging System, employing patented ultrasensitive imaging technologyThe i/Blue(TM) Imaging System is system compatible; system attaches to most endoscopesThe company recently closed the second tranche for the amount of US$1,415,500 of the Convertible Note offering Imagin Medical (CSE: IME) (OTCQB: IMEXF) is a surgical imaging company focused on advancing new methods of visualizing cancer during…

Tuesday Mar 16, 2021 - 2:35 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Set to Begin Enrolling Brain Cancer Drug Trial Participants

Brain cancer drug developer CNS Pharmaceuticals is finalizing preparations to begin March enrollment of patients in its potentially pivotal Phase 2 trial evaluating its promising lead candidate, Berubicin, for the overall survival improvement of glioblastoma (“GBM”) patientsGlioblastomas are a type of brain cancer that have continued to elude effective therapy over the past century of investigation, leaving patients with expectations of approximately 15 months of…

Monday Mar 15, 2021 - 2:15 pm

Healthy Extracts Inc. (HYEX) Reports 71% Revenue Increase Backed by Industry Momentum

Healthy Extracts Inc. officially changed its name from Grey Cloak Tech Inc. on March 1, formalizing the company’s shift into the health products industryHealthy Extracts currently wholly owns two subsidiaries, BergaMet North America (“NA”) and Ultimate Brain Nutrients (“UBN”), and reported a revenue increase of 71% from $748,377 in 2019 to $1,276,559 in the 12 months ending December 31, 2020This revenue growth is consistent with…

Monday Mar 15, 2021 - 12:17 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Revolutionary Technology a Cost Saver for Hospitals and Patients

White light cystoscopy (“WLC”) is the most commonly used procedure to detect non-muscle invasive bladder cancer (“NMIBC”)Despite its prevalence, WLC is not the most effective method and contributes to a high bladder cancer recurrence rateBlue light cystoscopy (“BLC”) is a more recent and highly effective method, but the high cost of equipment and skill level has impeded its uptake among hospitalsImagin Medical believes the i/Blue(TM)…

Articles

Articles Category: Biotechnology

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions